# RxCapital

RxCapital is a Private Equity based in Cambridge, United Kingdom.

## Overview

- **Organization type:** Private Equity
- **Headquarters:** Cambridge, United Kingdom
- **Region:** Europe
- **Address:** Cambridge, United Kingdom
- **Founded:** 2023
- **Assets under management:** Undisclosed
- **Website:** https://www.trxcap.com
- **LinkedIn:** https://www.linkedin.com/company/t-rx-capital

## Regulatory record

- **Reports private funds:** No

## About

RxCapital is the investment arm of RxCelerate, based in Cambridge, U.K. It invests in therapeutic and diagnostic assets, platform technologies, and digital tools for drug discovery and development. RxCapital has made one investment, in Rivus Pharmaceuticals, as part of their Series B on September 22, 2022.

## Sectors

- Digital Health
- Life Sciences
- Healthcare Services

## Questions

### What investment stages does RxCapital target?

RxCapital deploys capital at the earliest institutional stages — seed and Series A. The firm's typical check size ranges from £250,000 to £3 million, positioning it as a nucleus investor that can anchor a round before later-stage venture funds enter. Its stage focus aligns with the high-risk, pre-revenue profile of drug-development startups and early health-tech platforms.

### Which sectors does RxCapital explicitly avoid?

RxCapital does not invest outside healthcare. The firm's mandate excludes clean energy, fintech, enterprise software, consumer internet, and industrials — a deliberate narrowing that differentiates it from generalist venture shops. This sector discipline means the team evaluates fewer deals annually but with deeper clinical and scientific due diligence for each.

### How does RxCapital source proprietary deal flow?

The firm leans on the Cambridge life-science ecosystem — university spinouts, research-hospital collaborations, and technology-transfer offices — as primary sourcing channels. Its geographic concentration gives it early visibility into companies emerging from University of Cambridge labs and affiliated healthcare clusters before those startups are widely shopped to pan-European funds.

### Is RxCapital structured as a venture firm or a traditional private equity fund?

RxCapital operates as a venture-oriented private equity firm, not a buyout shop. It focuses on minority-equity investments in early-stage companies, earning returns through long-duration equity appreciation rather than financial engineering or leveraged dividends. The GP structure is the standard tiered partnership model for closed-end funds.

## Related profiles

- [RW Capital & Strategy](https://altss.com/profile/rw-capital-and-strategy)
- [S&G Investment](https://altss.com/profile/sandg-investment)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/rxcapital

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology